Form 4: Zoetis EVP Ashton Reports RSU Vesting, Stock Transactions
Insider Transaction Report
Zoetis Inc. Executive Vice President Nicholas Ashton reported the vesting and settlement of restricted stock units and related stock disposals for tax purposes.
Summary
- Executive Vice President Nicholas Ashton acquired 381 shares of Zoetis Inc. common stock on February 6, 2026, and 398 shares on February 8, 2026, through the vesting and settlement of restricted stock units (RSUs).
- Concurrently, Ashton disposed of 200 shares of common stock at $127.42 per share on February 6, 2026, and 209 shares at $127.42 per share on February 8, 2026, to cover tax withholding obligations.
- Following these transactions, Ashton beneficially owns 1,464 shares of Zoetis Inc. common stock.
- Ashton also holds 381 restricted stock units from a February 6, 2024 grant and 2,250.4257 restricted stock units from a February 19, 2025 grant, which will vest in future installments. All RSUs from the February 8, 2023 grant have now vested.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, reflecting standard executive compensation practices and not indicating any significant positive or negative operational or financial developments for Zoetis Inc.
Positives
- The vesting of restricted stock units indicates continued executive compensation and alignment of management interests with shareholder value.
- The acquisition of common stock increases the executive's direct ownership in the company.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, reflecting individual compensation events rather than broader industry trends or company-specific strategic shifts. These transactions are typical for executives receiving equity-based compensation.
Stakeholder Impact
- Minimal direct impact on shareholders as these are routine compensation events and do not reflect changes in company strategy or performance.
Next Steps
- Remaining one-third portions of the February 6, 2024 RSU grant are scheduled to vest on the second and third anniversaries of the grant date.
- One-third portions of the February 19, 2025 RSU grant are scheduled to vest on the first, second, and third anniversaries of the grant date.
Key Dates
| Date | Description |
|---|---|
| 02/08/2023 | Grant date for a tranche of Restricted Stock Units (RSUs), which fully vested on its third anniversary. |
| 02/06/2024 | Grant date for a tranche of Restricted Stock Units (RSUs), with one-third vesting on its first anniversary. |
| 02/19/2025 | Grant date for a tranche of Restricted Stock Units (RSUs), with future vesting on its first, second, and third anniversaries. |
| 02/06/2026 | Transaction date for RSU vesting, acquisition of common stock, and disposal of common stock for tax withholding. |
| 02/08/2026 | Transaction date for RSU vesting, acquisition of common stock, and disposal of common stock for tax withholding. |
| 02/10/2026 | Signature date of the filing. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of restricted stock units and subsequent sales for tax purposes. It does not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing does not alter the fundamental investment thesis for Zoetis Inc.
Keywords
Zoetis, ZTS, Form 4, Insider Transaction, Restricted Stock Units, Equity Compensation, Nicholas Ashton
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.